Angel News

Angel News

Back to Homepage

14th January 2019

Chronomics secures £1.12 million seed funding

Chronomics, a pioneering company in health-tech innovation, has just launched the world’s first consumer epigenetic testing kit. Chronomics has successfully secured more than £1.12 million in funding, including significant investment from venture capital firm Anthemis, and follow on funding from SOSV, one of the world’s most active early stage biotech investors.

The four founders of Chronomics are leading in their respective fields. Dr Tom Stubbs and Daniel Herranz worked at the forefront of epigenetics research at the University of Cambridge, where they collaborated with Dr Toby Call, a Bioenergy and Industrial Biotechnology expert, to define the first models. The team brought on board Charles Ball whose extensive commercial experience has helped to explain the intricacies of epigenetic science to the public.

14th January 2019

Open Bionics attracts £1.5m investment from Foresight Williams

Foresight Group has invested £1.5 million from the Foresight Williams Technology EIS Fund into Open Bionics Limited.

The investment has been made alongside an identical commitment from Downing LLP and Ananda Impact Ventures of £1.5m each and Rathbone Nominees to complete the £4.66m round.

Open Bionics is an award-winning designer, manufacturer and supplier of bionic limbs with ambitions to become a market leader in a range of bespoke prostheses and assistive technologies and a global supplier of prosthetic and orthotic products and services.  Based in Bristol, the Company was founded just four years ago by CEO Joel Gibbard and COO Samantha Payne, since when the team has grown to 23

10th January 2019

Lein Applied Diagnostics receives funding from Henley Business Angels

Lein Applied Diagnostics, a company that specialises in innovative and precise optical technology, have closed their latest funding round, receiving investment from two members of Henley Business Angels. This is the second time that Lein have gone through Henley Business Angels for funding, having previously raised a total of £440,000 back in 2017.

8th January 2019

Silicon Valley Bank’s 2019 Healthcare Report: record investment in the U.S. and Europe

Healthcare venture investment in the U.S. and Europe reached a new high in 2018, according to Silicon Valley Bank, the bank of the world’s most innovative companies and their investors. Investment totals in 2018 grew more than 50 percent over 2017, with the activity due in large part to record Series A investments in U.S. biopharma companies.

19th December 2018

Renephra raises significant funding from NorthInvest

An innovative treatment for those suffering from the effects of a debilitating medical condition is now a step closer after a significant investment from NorthInvest.

Created by doctors who work on the front line, the technology developed by Renephra helps patients dealing with chronic fluid overload including Lymphoedema – a condition which affects 200 thousand people across the UK.

The treatment aims to improve a patient’s quality of life, allowing them to spend more time with friends, family and loved ones. Treatment which would normally take place in a hospital setting will now be able to be administered at home.

17th December 2018

YFM Equity Partners sells Mangar Health

YFM Equity Partners has sold its stake in Mangar Health Limited for an undisclosed sum to Winncare Group Ltd, a leading French medical device company, delivering a 2.7x return to investors. 

Mangar Health designs, manufactures and supplies inflatable bathing and lifting devices, which protect carers from injury and promote independence for people with limited mobility. With a global reach into America, Canada and Australia, Mangar Health also offers a wide international distribution network and additional opportunities in healthcare markets such as emergency services.  The Company is led by CEO Simon Claridge and his team of Finance and Operations Director Craig Butcher, Commercial Director Andrew Macphail and Marketing Director Clare Birt.

14th December 2018

Digital GP service receives £1 million investment from Maven

A Coventry-firm responsible for creating a web platform that provides online services for general medical consultations and prescriptions has received a £1million funding package. This will allow The GP Service (UK) Limited to create over 60 new roles by 2023 - a five-fold increase in the team’s current size.

12th December 2018

eHealth Ventures Invests in Engineering for All

eHealth Ventures, the leading Digital Health technological incubator in Israel, has announced the acceptance of its 8th portfolio company - Engineering for All ("EfA"), managed by Yoel Ezra, an elite IDF technology unit veteran with many years of R&D management experience. eHealth Ventures has invested $900,000 in the company's seed financing round.

29th November 2018

New Company Accepted at the eHealth Ventures Incubator

eHealth Ventures, the leading Digital Health technological incubator in Israel, has announced the acceptance of its 7th portfolio company - TrainPain, managed by Dr. Elan Schneider DPT, an internationally recognized expert in chronic pain rehabilitation.

27th November 2018

OMass Therapeutics announces £14 M Series A financing

OMass Therapeutics, a biopharmaceutical company using structural mass spectrometry to discover novel medicines, has announced completion of a £14 million Series A financing. New investor Syncona Ltd led the round, alongside Oxford Sciences Innovation. The financing supports development of a pipeline of drug development programmes.

26th November 2018

BGF invests in protein analysis biotech firm Fluidic Analytics

Fluidic Analytics, a Cambridge-based life sciences business, has secured a £24m funding package to continue its research and development plans after launching a transformative protein analysis tool. BGF is providing £5m of growth capital in a funding round with Delin Ventures and existing shareholders including Draper Esprit and IQ Capital.

22nd November 2018

Thermetrix Ltd secures £500k to develop innovative diabetic footcare device

Thermetrix Ltd has secured £500,000 investment for their latest venture to support the development of a diabetic footcare system.  The funding includes £200,000 seed investment from the Development Bank of Wales as well as business angels and corporate support.

The equity investment, which has come from the Wales Technology Seed Fund, will also back the launch of Podium, for both home and professional use, working with nursing homes, podiatrists and other medical professionals.

Established in 2018, Thermetrix, based in Abercynon is working with a team of experts to produce Podium, giving people with diabetes an easy and fast way to check the soles of their feet and seek earlier intervention from their healthcare team to prevent further complications. Using thermal imaging technology, the system can be used to take a daily image of their feet which can then be shared with their podiatrist or GP through a cloud-based dashboard app.

PREVIOUSItems 12 of 122NEXT

Back to Homepage